18 March 2016 - The SMC has announced forthcoming submissions for the following medicines: carfilzomib (Kyprolis), dasatinib monohydrate (Sprycel), emtricitabine with tenofovir alafenamide fumarate (Descovy), fosfomycin tometamol (Monouril), iron (Fe III) isomaltoside (Diafer) & rilpivirine hydrochloride (Edurant).

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/